{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T10:36:01Z","timestamp":1756636561351},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Anatomy - Anatomischer Anzeiger"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.aanat.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T15:39:20Z","timestamp":1558107560000},"page":"153-160","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Modulatory effect of empagliflozin on cellular parameters of endocrine pancreas in experimental pre-diabetes"],"prefix":"10.1016","volume":"224","author":[{"given":"Ahmed A.M","family":"Abdel-Hamid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa El-Din L.","family":"Firgany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.aanat.2019.05.002_bib0005","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/dom.13031","article-title":"Signals in the pancreatic islet microenvironment influence beta-cell proliferation","volume":"19","author":"Aamodt","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.aanat.2019.05.002_bib0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10735-016-9664-5","article-title":"Hydroxychloroquine hindering of diabetic isletopathy carries its signature on the inflammatory cytokines","volume":"47","author":"Abdel-Hamid","year":"2016","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.aanat.2019.05.002_bib0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.acthis.2018.10.005","article-title":"Correlation between pancreatic mast cells and the low grade inflammation in adipose tissue of experimental prediabetes","volume":"121","author":"Abdel-Hamid","year":"2019","journal-title":"Acta Histochem."},{"key":"10.1016\/j.aanat.2019.05.002_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2019.04.009","article-title":"Increased mast cell number is associated with a decrease in beta-cell mass and regeneration in type 2 diabetic rats","author":"Abdel-Hamid","year":"2019","journal-title":"Acta Histochem."},{"key":"10.1016\/j.aanat.2019.05.002_bib0025","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.acthis.2016.06.002","article-title":"Favorable outcomes of hydroxychloroquine in insulin resistance may be accomplished by adjustment of the endothelial dysfunction as well as the skewed balance of adipokines","volume":"118","author":"Abdel-Hamid","year":"2016","journal-title":"Acta Histochem."},{"key":"10.1016\/j.aanat.2019.05.002_bib0030","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pcd.2014.02.005","article-title":"The role of incretin-based therapies in prediabetes: a review","volume":"8","author":"Ahmadieh","year":"2014","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.aanat.2019.05.002_bib0035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.acthis.2016.01.004","article-title":"Tubal cytokine changes accompany the epithelial atypia of letrozole-stimulated ovaries","volume":"118","author":"Abdel-Hamid","year":"2016","journal-title":"Acta Histochem."},{"key":"10.1016\/j.aanat.2019.05.002_bib0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/iep.12196","article-title":"Reversal of tubo-ovarian atypical epithelial patterns after cessation of ovarian stimulation by letrozole","volume":"97","author":"Abdel-Hamid","year":"2016","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.aanat.2019.05.002_bib0045","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.yexmp.2017.02.017","article-title":"Vascular and cellular changes accompany altered expression of angiopoietins in placenta of non-complicated ART pregnancies","volume":"102","author":"Abdel-Hamid","year":"2017","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.aanat.2019.05.002_bib0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bcp.2011.10.003","article-title":"A novel long acting DPP-IV inhibitor PKF-275-055 stimulates beta-cell proliferation resulting in improved glucose homeostasis in diabetic rats","volume":"83","author":"Akarte","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.aanat.2019.05.002_bib0055","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1007\/s10620-016-4344-6","article-title":"Increased proliferative activity accompanies the local inflammatory response of gastric mucosa after intragastric balloon insertion","volume":"61","author":"Atef","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.aanat.2019.05.002_bib0060","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201601019","article-title":"Advanced glycation end products stimulate gene expression of fibroblast growth factor 23","volume":"61","author":"Bar","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.aanat.2019.05.002_bib0065","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4240136","article-title":"Comparative analysis of AGE and RAGE levels in human somatic and embryonic stem cells under H2O2-induced noncytotoxic oxidative stress conditions","volume":"2017","author":"Barandalla","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.aanat.2019.05.002_bib0070","article-title":"Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion","author":"Bonner","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.aanat.2019.05.002_bib0075","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2174\/156652412802480970","article-title":"Effects of combining linagliptin treatment with BI-38335, a novel SGLT2 inhibitor, on pancreatic islet function and inflammation in db\/db mice","volume":"12","author":"Chen","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.aanat.2019.05.002_bib0080","article-title":"The effects of empagliflozin, an SGLT2 inhibitor, on pancreatic beta-cell mass and glucose homeostasis in type 1 diabetes","volume":"11","author":"Cheng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.aanat.2019.05.002_bib0085","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/00325481.2017.1259544","article-title":"Efficacy and safety of empagliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials","volume":"129","author":"Devi","year":"2017","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.aanat.2019.05.002_bib0090","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2337\/diabetes.50.5.1021","article-title":"Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death","volume":"50","author":"Finegood","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.aanat.2019.05.002_bib0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/1479164114561992","article-title":"Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences","volume":"12","author":"Gallo","year":"2015","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.aanat.2019.05.002_bib0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1507\/endocrj.EJ12-0094","article-title":"Liraglutide prevents diabetes progression in prediabetic OLETF rats","volume":"60","author":"Guo","year":"2013","journal-title":"Endocr. J."},{"key":"10.1016\/j.aanat.2019.05.002_bib0105","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00125-016-4158-2","article-title":"The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE (-\/-) mice fed a western diet","volume":"60","author":"Han","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.aanat.2019.05.002_bib0110","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/jpet.114.213454","article-title":"The sodium glucose cotransporter type 2 inhibitor empagliflozin preserves beta-cell mass and restores glucose homeostasis in the male zucker diabetic fatty rat","volume":"350","author":"Hansen","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.aanat.2019.05.002_bib0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/wrr.12144","article-title":"Glycation of extracellular matrix proteins impairs migration of immune cells","volume":"22","author":"Haucke","year":"2014","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.aanat.2019.05.002_bib0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1530\/REP-14-0149","article-title":"Accumulation of advanced glycation end products in the rabbit blastocyst under maternal diabetes","volume":"148","author":"Haucke","year":"2014","journal-title":"Reproduction"},{"key":"10.1016\/j.aanat.2019.05.002_bib0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/1753-0407.12494","article-title":"Beneficial effects of sodium-glucose cotransporter 2 inhibitors for preservation of pancreatic beta-cell function and reduction of insulin resistance","volume":"9","author":"Kaneto","year":"2017","journal-title":"J. Diabetes"},{"key":"10.1016\/j.aanat.2019.05.002_bib0130","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/dom.13400","article-title":"Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic beta-cells in db\/db mice: the earlier and longer, the better","volume":"20","author":"Kimura","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.aanat.2019.05.002_bib0135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/dom.12779","article-title":"Dapagliflozin once-daily and exenatide once-weekly dual therapy: a 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes","volume":"19","author":"Lundkvist","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.aanat.2019.05.002_bib0140","first-page":"772","article-title":"Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic beta-cells in obese type 2 diabetic db\/db mice","volume":"470","author":"Miyoshi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.aanat.2019.05.002_bib0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mad.2017.07.009","article-title":"Dicarbonyls induce senescence of human vascular endothelial cells","volume":"166","author":"Navarrete Santos","year":"2017","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.aanat.2019.05.002_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112394","article-title":"The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity","volume":"9","author":"Oelze","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.aanat.2019.05.002_bib0155","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bbrc.2015.10.109","article-title":"Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic beta-cells in obese type 2 diabetic db\/db mice","volume":"470","author":"Okauchi","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.aanat.2019.05.002_bib0160","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","article-title":"Role of advanced glycation end products in cellular signaling","volume":"2","author":"Ott","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.aanat.2019.05.002_bib0165","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4239\/wjd.v5.i6.817","article-title":"Incretin-based therapies in prediabetes: current evidence and future perspectives","volume":"5","author":"Papaetis","year":"2014","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.aanat.2019.05.002_bib0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.14310\/horm.2002.1196","article-title":"Relative iron \u201coverload\u201d in offspring of patients with type 2 diabetes mellitus: a new component in the conundrum of insulin resistance syndrome?","volume":"2","author":"Psyrogiannis","year":"2003","journal-title":"Hormones (Athens, Greece)"},{"key":"10.1016\/j.aanat.2019.05.002_bib0175","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.diabet.2017.04.002","article-title":"Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells","volume":"43","author":"Solini","year":"2017","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.aanat.2019.05.002_bib0180","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.1152\/ajpendo.00040.2013","article-title":"Adaptive beta-cell proliferation increases early in high-fat feeding in mice, concurrent with metabolic changes, with induction of islet cyclin D2 expression","volume":"305","author":"Stamateris","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.aanat.2019.05.002_bib0185","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.redox.2017.06.009","article-title":"The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats","volume":"13","author":"Steven","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.aanat.2019.05.002_bib0190","doi-asserted-by":"crossref","first-page":"6864","DOI":"10.1038\/s41598-018-25126-z","article-title":"Effect of the sodium-glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db\/db mice of different age","volume":"8","author":"Takahashi","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Annals of Anatomy - Anatomischer Anzeiger"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940960219300640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940960219300640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T14:40:47Z","timestamp":1560436847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0940960219300640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":38,"alternative-id":["S0940960219300640"],"URL":"https:\/\/doi.org\/10.1016\/j.aanat.2019.05.002","relation":{},"ISSN":["0940-9602"],"issn-type":[{"type":"print","value":"0940-9602"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulatory effect of empagliflozin on cellular parameters of endocrine pancreas in experimental pre-diabetes","name":"articletitle","label":"Article Title"},{"value":"Annals of Anatomy - Anatomischer Anzeiger","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aanat.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}